Open AccessSurvival of castration‐resistant prostate cancer patients treated with dendritic–tumor cell hybridomas is negatively correlated with changes in peripheral blood CD56 bright CD16 − natural killer cells
Author(s) -
Haque Chowdhury Helena,
Hawlina Simon,
Gabrijel Mateja,
Trkov Bobnar Saša,
Kreft Marko,
Lenart Gordan,
Cukjati Marko,
Kopitar Andreja Nataša,
Kejžar Nataša,
Ihan Alojz,
Ležaič Luka,
Grmek Marko,
Kmetec Andrej,
Jeras Matjaž,
Zorec Robert
Publication year - 2021
Publication title -
clinical and translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2001-1326
DOI - 10.1002/ctm2.505
Subject(s) - medicine , antigen , immune system , immunotherapy , prostate cancer , immunology , elispot , dendritic cell , cancer , t cell , oncology